Summary

The global non-invasive aesthetic treatment market was valued at $15,510.94 million in 2022, and is projected to reach $37,471.03 million by 2032, registering a CAGR of 9.2% from 2023 to 2032. 
Non-invasive aesthetic treatment encompasses a wide range of cosmetic procedures and therapies that enhance an individual's physical appearance and address various concerns without the need for surgical intervention. These treatments are designed to improve skin quality, reduce signs of aging, and enhance specific features, often with minimal discomfort, minimal to no downtime, and a lower risk of complications compared to invasive surgical options. Common non-invasive treatments include Botox injections, dermal fillers, laser therapy, chemical peels, and microdermabrasion, among others. These procedures typically target issues such as wrinkles, fine lines, acne scars, skin texture irregularities, and volume loss. The non-invasive aesthetic treatment industry is characterized by ongoing advancements in technology and a growing demand driven by societal pressures and the pursuit of a more youthful and appealing appearance. 
The rise in awareness about non-invasive aesthetic treatment procedures, as well as the increase in adoption of this procedure among the elderly and young population for enhancing their appearance, is driving the growth of the non-invasive aesthetic treatment market. For instance, according to the International Society of Aesthetic Plastic Surgeons (IASPS), the number of non-surgical fat reduction procedures performed on individuals under the age of 18 has been steadily increasing in recent years. In 2020, the ASPS reported that there were approximately 24,488 non-surgical fat reduction procedures performed on individuals under the age of 18, which represents a 3.4% of the total non-surgical fat reduction procedures. 

In addition, technological advancements play a pivotal role in driving the growth of the non-invasive aesthetics market. These innovations have revolutionized the industry by making procedures safer, more effective, and appealing to a wider range of patients. One significant impact of technological advancements is the development of non-invasive alternatives to surgical procedures. For instance, the introduction of advanced laser technology has enabled a variety of skin resurfacing and resurfacing procedures, including laser hair removal, tattoo removal, and skin tightening. These treatments often have reduced downtime, lower risk, and offer more predictable outcomes than their surgical counterparts. In addition, these advances have allowed for more comfortable and painless procedures, further encouraging patients to consider non-invasive aesthetic treatments. 
However, the non-invasive aesthetics market faces growth restraints, primarily due to high costs and inconsistent results. The expense of these treatments be prohibitive for many individuals, limiting their accessibility. Moreover, inconsistent outcomes, varying from person to person, lead to patient dissatisfaction. The combination of cost concerns and uncertain results deter potential clients and affect market expansion, making affordability and effectiveness crucial considerations for both providers and patients. 

The non-invasive aesthetic treatment market is segmented on the basis of procedure, gender, age group, and end user and region. On the basis of procedure, the market is classified into injectables, skin resurfacing, and others. The injectables segment is further divided into neurotoxins, HA filler and non-HA fillers. The skin resurfacing segment is further divided into chemical peel, laser skin resurfacing, and microdermabrasion. The others segment is further bifurcated into laser hair removal, non-surgical fat reduction, sclerotherapy and others. On the basis gender, the market is categorized into female and male. On the basis age group, the market is segregated into 13 to 39, 40 to 54, 55 to 69, age 70 and over. On the basis of end user, market is fragmented into specialty & dermatology clinics, hospital, and others. Region-wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).  
The major key players that operate in the global non-invasive aesthetic treatment market are Cynosure Inc Sisram Medical Ltd, Abbvie Inc, Lumenis Ltd., Candela Corporation, Fotona, HTM Eletronica MerzPharma., Cutera and Bausch Health Companies Inc. 

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the non-invasive aesthetic treatment market analysis from 2022 to 2032 to identify the prevailing non-invasive aesthetic treatment market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the non-invasive aesthetic treatment market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global non-invasive aesthetic treatment market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Additional company profiles with specific to client's interest
● Expanded list for Company Profiles
● Historic market data
Key Market Segments
By Procedure
● Injectables
○ Type
○ Neurotoxins
○ Hyaluronic Acid Fillers
○ Non Hyaluronic Fillers
● Skin Resurfacing
○ Type
○ Microdermabration
○ Laser skin resurfacing
○ Chemical peel
● Others
○ Type
○ Laser Hair Removal
○ Nonsurgical Fat Reduction
○ Sclerotherapy
○ Others
By Gender
● Female
● Male
By Age Group
● 13 to 39
● 40 to 54
● 55 to 69
● Age 70 and Over
By End User
● Specialty and Dermatology Clinics
● Hospitals
● Others
By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ France
○ UK
○ Italy
○ Spain
○ Rest of Europe
● Asia-Pacific
○ Japan
○ China
○ India
○ Australia
○ South Korea
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ South Africa
○ Rest of LAMEA
● Key Market Players
○ Cynosure Inc
○ Sisram Medical Ltd.
○ Candela Corporation.
○ Fotona
○ HTM Eletronica
○ Cutera
○ AbbVie Inc.
○ Lumenis Ltd.
○ MerzPharma
○ Bausch Health Companies Inc.

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. Modertae threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Modertae intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in consciousness regarding physical appearance
3.4.1.2. Rise in adoption of non-invasive aesthetic procedures
3.4.1.3. Technological advancements in non-invasive aesthetic treatment
3.4.2. Restraints
3.4.2.1. High cost of non-invasive aesthetic treatment
3.4.2.2. Inconsistent results
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets 
CHAPTER 4: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY PROCEDURE
4.1. Overview
4.1.1. Market size and forecast
4.2. Injectables
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.2.4. Injectables Non-invasive Aesthetic Treatment Market by Type
4.3. Skin Resurfacing
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.3.4. Skin Resurfacing Non-invasive Aesthetic Treatment Market by Type
4.4. Others
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.4.4. Others Non-invasive Aesthetic Treatment Market by Type
CHAPTER 5: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY GENDER
5.1. Overview
5.1.1. Market size and forecast
5.2. Female
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Male
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY AGE GROUP
6.1. Overview
6.1.1. Market size and forecast
6.2. 13 to 39
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. 40 to 54
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. 55 to 69
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
6.5. Age 70 and Over
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by region
6.5.3. Market share analysis by country
CHAPTER 7: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Specialty and Dermatology Clinics
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Hospitals
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Others
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: NON-INVASIVE AESTHETIC TREATMENT MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Procedure
8.2.3. Market size and forecast, by Gender
8.2.4. Market size and forecast, by Age Group
8.2.5. Market size and forecast, by End User
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Procedure
8.2.6.1.2. Market size and forecast, by Gender
8.2.6.1.3. Market size and forecast, by Age Group
8.2.6.1.4. Market size and forecast, by End User
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Procedure
8.2.6.2.2. Market size and forecast, by Gender
8.2.6.2.3. Market size and forecast, by Age Group
8.2.6.2.4. Market size and forecast, by End User
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Procedure
8.2.6.3.2. Market size and forecast, by Gender
8.2.6.3.3. Market size and forecast, by Age Group
8.2.6.3.4. Market size and forecast, by End User
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Procedure
8.3.3. Market size and forecast, by Gender
8.3.4. Market size and forecast, by Age Group
8.3.5. Market size and forecast, by End User
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Procedure
8.3.6.1.2. Market size and forecast, by Gender
8.3.6.1.3. Market size and forecast, by Age Group
8.3.6.1.4. Market size and forecast, by End User
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Procedure
8.3.6.2.2. Market size and forecast, by Gender
8.3.6.2.3. Market size and forecast, by Age Group
8.3.6.2.4. Market size and forecast, by End User
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Procedure
8.3.6.3.2. Market size and forecast, by Gender
8.3.6.3.3. Market size and forecast, by Age Group
8.3.6.3.4. Market size and forecast, by End User
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Procedure
8.3.6.4.2. Market size and forecast, by Gender
8.3.6.4.3. Market size and forecast, by Age Group
8.3.6.4.4. Market size and forecast, by End User
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Procedure
8.3.6.5.2. Market size and forecast, by Gender
8.3.6.5.3. Market size and forecast, by Age Group
8.3.6.5.4. Market size and forecast, by End User
8.3.6.6. Rest of Europe
8.3.6.6.1. Market size and forecast, by Procedure
8.3.6.6.2. Market size and forecast, by Gender
8.3.6.6.3. Market size and forecast, by Age Group
8.3.6.6.4. Market size and forecast, by End User
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Procedure
8.4.3. Market size and forecast, by Gender
8.4.4. Market size and forecast, by Age Group
8.4.5. Market size and forecast, by End User
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Procedure
8.4.6.1.2. Market size and forecast, by Gender
8.4.6.1.3. Market size and forecast, by Age Group
8.4.6.1.4. Market size and forecast, by End User
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Procedure
8.4.6.2.2. Market size and forecast, by Gender
8.4.6.2.3. Market size and forecast, by Age Group
8.4.6.2.4. Market size and forecast, by End User
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Procedure
8.4.6.3.2. Market size and forecast, by Gender
8.4.6.3.3. Market size and forecast, by Age Group
8.4.6.3.4. Market size and forecast, by End User
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Procedure
8.4.6.4.2. Market size and forecast, by Gender
8.4.6.4.3. Market size and forecast, by Age Group
8.4.6.4.4. Market size and forecast, by End User
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Procedure
8.4.6.5.2. Market size and forecast, by Gender
8.4.6.5.3. Market size and forecast, by Age Group
8.4.6.5.4. Market size and forecast, by End User
8.4.6.6. Rest of Asia-Pacific
8.4.6.6.1. Market size and forecast, by Procedure
8.4.6.6.2. Market size and forecast, by Gender
8.4.6.6.3. Market size and forecast, by Age Group
8.4.6.6.4. Market size and forecast, by End User
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Procedure
8.5.3. Market size and forecast, by Gender
8.5.4. Market size and forecast, by Age Group
8.5.5. Market size and forecast, by End User
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Procedure
8.5.6.1.2. Market size and forecast, by Gender
8.5.6.1.3. Market size and forecast, by Age Group
8.5.6.1.4. Market size and forecast, by End User
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Procedure
8.5.6.2.2. Market size and forecast, by Gender
8.5.6.2.3. Market size and forecast, by Age Group
8.5.6.2.4. Market size and forecast, by End User
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Procedure
8.5.6.3.2. Market size and forecast, by Gender
8.5.6.3.3. Market size and forecast, by Age Group
8.5.6.3.4. Market size and forecast, by End User
8.5.6.4. Rest of LAMEA
8.5.6.4.1. Market size and forecast, by Procedure
8.5.6.4.2. Market size and forecast, by Gender
8.5.6.4.3. Market size and forecast, by Age Group
8.5.6.4.4. Market size and forecast, by End User
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2022
CHAPTER 10: COMPANY PROFILES
10.1. Cynosure Inc
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.2. AbbVie Inc.
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Sisram Medical Ltd.
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.4. Candela Corporation.
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Key strategic moves and developments
10.5. Lumenis Ltd.
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Key strategic moves and developments
10.6. Bausch Health Companies Inc.
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.6.6. Business performance
10.7. MerzPharma
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.8. Fotona
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.9. HTM Eletronica
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.10. Cutera
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
10.10.6. Business performance
10.10.7. Key strategic moves and developments